Medical/Pharmaceuticals
Merck Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer
Not intended for US-, Canada- or UK-based media DARMSTADT, Germany, March 16, 2021 /PRNewswire/ -- Merck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of ...
2021-03-16 15:00
2829
Sihuan Pharmaceutical (0460.HK): 'A Friend of Time' 2021 - The Turning-point Year
HONG KONG, March 16, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal role in China's domestic medical industry and is a leading company for the development of the country's cardio-cerebral vascular prescription drugs. According to IMS data in 2018, Sihuan Pharmaceut...
2021-03-16 14:48
3540
QBiotics Welcomes TDM Growth Partners As Cornerstone Investor in a Capital Raise To Accelerate Drug Development Timelines
Key highlights: * QBiotics welcomes TDM Growth Partners as cornerstone investor * TDM Growth Partners is investing A$50 million into QBiotics to accelerate QBiotics' human drug development pipeline, support marketing of the company's veterinary pharmaceutical STELFONTA® and strengthen the QBi...
2021-03-16 06:35
2644
CBC Group Announces the Appointment of Roger Perlmutter as Science Partner
SHANGHAI, March 15, 2021 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, is pleased to announce that Roger M. Perlmutter, M.D., Ph.D., currently non-Executive Chairman, Merck Research Laboratories, joins CBC as Science Partner and a member of its Scientific Advisory Bo...
2021-03-15 22:00
2766
BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs
VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...
2021-03-15 20:00
3036
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...
2021-03-15 19:00
5078
Antengene Included in the Shenzhen-Hong Kong Stock Connect
SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and o...
2021-03-15 09:40
3499
Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea
SHANGHAI and SEOUL, South Korea, March 15, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolo...
2021-03-15 08:00
3655
Agiomix Receives the First ISO 15189 Accreditation for Next Generation Sequencing in the Region
DUBAI, UAE, March 15, 2021 /PRNewswire/ -- Agiomix has received the ISO
15189:2012 Accreditation from the Emirates International Accreditation Centre
for Next Generation Sequencing clinical assays.
2021-03-15 07:50
2226
SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria
MELBOURNE, Australia, March 15, 2021 /PRNewswire/ -- SuperTrans Medical has announced the appointment of three Australian companies to play pivotal roles in an upcoming clinical drug trial that offers new hope in the plight against antimicrobial resistance (AMR), which the World Health Organisati...
2021-03-15 07:08
1669
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately$1 billion, which includes buyer's assumption of certain liabilities and seller's retention o...
2021-03-12 22:00
8574
Harbour BioMed Announces Dosing of First Patient in Tanfanercept Phase III Clinical Trial
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI and SUZHOU, China, March 12, 2021 /PRNewswire/ -- Harbour BioMed (HBM) (HKEX: 02142) today announced the dosing of the first patient in the Phase III clinical trial of its new global investigational tumor necrosis factor (TNF) receptor-1 f...
2021-03-12 09:00
5683
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials
- 100% protection against severe disease - Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19 - Efficacy against variants confirmed in U.K. and South Africa GAITHERSBURG, Md., March 12, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnolog...
2021-03-12 05:04
3943
A large randomized clinical trial shows significant reduction in urinary tract infections
STOCKHOLM, March 12, 2021 /PRNewswire/ -- A recently published, randomized, controlled multicenter study inIndia shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard cat...
2021-03-12 01:30
2023
Elekta's Board of Directors proposes additional dividend of SEK 0.90 per share
STOCKHOLM, March 12, 2021 /PRNewswire/ -- The Board of Directors of Elekta (EKTA-B.ST) proposes an extra dividend for the fiscal year 2019/20. According to the communication in connection with the ordinary dividend, the Board announced that Elekta may propose an additional dividend so that the t...
2021-03-12 01:12
4505
Global Medical Imaging Informatics Market Accelerated by Cloud and AI to Enable Deployment Options and Support Decision-making
Modern informatics solutions will drive revenue in developed markets as hospitals try to improve productivity and efficiency within imaging departments, finds Frost & Sullivan SANTA CLARA, Calif., March 12, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the emergence of new t...
2021-03-12 00:34
2517
U.S. and EU Kidney Groups Align for Global Innovation Consortium
WASHINGTON, March 11, 2021 /PRNewswire/ -- The American Association of Kidney Patients (AAKP), the largest U.S. kidney patient organization, today joined the European Kidney Patients' Federation (EKPF) and the European Kidney Health Alliance (EKHA) in a new collaboration designed to expand the ro...
2021-03-11 21:58
2065
Gore REDUCE Clinical Study Five-Year Results Demonstrate That PFO Closure With The GORE® CARDIOFORM Septal Occluder Provides Safe Long-Term Reduction Of Recurrent Stroke
- Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone.*,¹ - Long-term results highlight GORE® CARDIOFORM Septal Occluder can be trusted for patient safety ...
2021-03-11 20:00
2947
Baxter Announces New Data on Benefits of Remote Patient Management for Home Peritoneal Dialysis World Kidney Day 11 March 2021
* Published economic modelling shows estimated reduction in hospital episodes and potential financial savings from remote patient monitoring technology. * Baxter supports World Kidney Day Steering Committee in declaring 2021 the year of "Living Well with Kidney Disease". SINGAPORE, March 11, 2...
2021-03-11 16:38
2851
Zymo Research Receives 510(k) Clearance for its Collection/Transport Device for COVID-19
IRVINE, Calif., March 11, 2021 /PRNewswire/ -- Zymo Research announced today the U.S. Food and Drug Administration (FDA) has cleared itsDNA/RNA Shield™ Collection Tube as a Class II medical device. The FDA's 510(k) clearance allows the product to be used as an In-vitro Diagnostic (IVD) device for...
2021-03-11 14:37
2537
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00TAILG's First Flagship Store in Indonesia Grandly Opens
[Picked up by 283 media titles]
2024-11-22 21:59
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12186
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
8234
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
7987
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
7409
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
5732